Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Altimmune (ALT) Non-Current Deferred Tax Liability (2017 - 2019)

Historic Non-Current Deferred Tax Liability for Altimmune (ALT) over the last 3 years, with Q2 2019 value amounting to $58500.0.

  • Altimmune's Non-Current Deferred Tax Liability fell 9867.98% to $58500.0 in Q2 2019 from the same period last year, while for Jun 2019 it was $58500.0, marking a year-over-year decrease of 9867.98%. This contributed to the annual value of $58500.0 for FY2018, which is 9901.49% down from last year.
  • Latest data reveals that Altimmune reported Non-Current Deferred Tax Liability of $58500.0 as of Q2 2019, which was down 9867.98% from $58500.0 recorded in Q1 2019.
  • In the past 5 years, Altimmune's Non-Current Deferred Tax Liability registered a high of $8.5 million during Q2 2017, and its lowest value of $58500.0 during Q4 2018.
  • Its 3-year average for Non-Current Deferred Tax Liability is $4.0 million, with a median of $4.4 million in 2018.
  • Over the last 5 years, Altimmune's Non-Current Deferred Tax Liability had its largest YoY gain of 4813.97% in 2018, and its largest YoY loss of 9901.49% in 2018.
  • Altimmune's Non-Current Deferred Tax Liability (Quarter) stood at $5.9 million in 2017, then tumbled by 99.01% to $58500.0 in 2018, then changed by 0.0% to $58500.0 in 2019.
  • Its Non-Current Deferred Tax Liability stands at $58500.0 for Q2 2019, versus $58500.0 for Q1 2019 and $58500.0 for Q4 2018.